Menopause: Clustering of metabolic syndrome components and population changes in insulin resistance

Climacteric

Volumn 14, Issue 1, 2011, Pages 83-91

  Lejskova M ^a   Alusik S ^a   Suchanek M ^b   Zecova S ^a   Pitha J ^c  

^a FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

blood pressure; cardiovascular disease; central obesity; dyslipidemia; insulin resistance; Menopause; metabolic syndrome

Indexed keywords

INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; MORBIDITY; POPULATION BASED CASE CONTROL STUDY; POPULATION DYNAMICS; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

CHOLESTEROL, HDL; CZECH REPUBLIC; FEMALE; HUMANS; INSULIN RESISTANCE; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 79951628143     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697131003692745     Document Type: Article

References (33)

1. Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:9-171
2. World Health Organization Statistical Information system. 2007. Available at: www.who.int/whosis/. Accessed November 26, 2009
3. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007;30:8-13 (Pubitemid 46052493)
4. Janssen I, Powell LH, Crawford S, et al. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008;168:1568-75
5. Torréns JI, Sutton-Tyrrell K, Zhao X, et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: Study of Women's Health Across the Nation. Menopause 2009;16:257-64
6. Weinberg ME, Manson JE, Buring JE, et al. Low sex hormonebinding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006;55:1473-80 (Pubitemid 44537344)
7. Mesch VR, Siseles NO, Maidana PN, et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008;11:509-17
8. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-11 (Pubitemid 36724404)
9. Cifkova R, Pitha J, Lejskova M, et al. Blood pressure around the menopause: a population study. J Hypertens 2008;26:1976-82
10. Piché ME, Lapointe A, Weisnagel SJ, et al. Regional body fat distribution and metabolic profile in postmenopausal women. Metabolism 2008;57:1101-7 (Pubitemid 351978070)
11. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-32 (Pubitemid 33636071)
12. Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care 2000;23:801-6 (Pubitemid 30414197)
13. Qader SS, Shakir YA, Nyberg P, et al. Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study. Climacteric 2008;11:475-82
14. Evolahti A, Hultcrantz M, Collins A. Psychosocial work environment and lifestyle as related to lipid profiles in perimenopausal women. Climacteric 2009;12:131-45
15. Villa P, Sagnella F, Perri C, et al. Low-and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women. Climacteric 2008;11:498-508
16. Gupta P, Harte A, Sturdee DW, et al. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks. Climacteric 2008;11:364-72
17. Koga M, Saito H, Mukai M, et al. Factors contributing to increased serum urate in postmenopausal Japanese females. Climacteric 2009;12:146-52
18. Dupuy AM, Carrière I, Scali J, et al. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents. Climacteric 2008;11:74-83
19. Molarius A, Seidell JC, Sans S, et al. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. Int J Obes Relat Metab Disord 1999;23:116-25 (Pubitemid 29057504)
20. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-72 (Pubitemid 34002968)
21. Harlow SD, Crawford S, Dennerstein L, et al. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 2007;10:112-19 (Pubitemid 46482175)
22. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80
23. Meisinger C, Thorand B, Schneider A, et al. Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 2002;162:82-9 (Pubitemid 34073405)
24. Kolmogorov-Smirnov test from Wikipedia. Available at: http://en. wikipedia.org/wiki/Kolmogorov%E2%80%93Smirnov-test. Accessed November 26, 2009
25. Kuiper's test from Wikipedia. Available at: http://en. wikipedia.org/wiki/Kuiper's-test. Accessed November 26, 2009
26. Ferrara CM, Lynch NA, Nicklas BJ, et al. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-70
27. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004;89:2601-7 (Pubitemid 38766338)
28. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607 (Pubitemid 19004941)
29. Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007;92:895-901 (Pubitemid 46465660)
30. Tchernof A, Desmeules A, Richard C, et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 2004;89:3425-30 (Pubitemid 38951915)
31. Petri Nahas EA, Padoani NP, Nahas-Neto J, et al. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric 2009;12:431-8
32. Mesch VR, Boero LE, Siseles NO, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006;9:40-8 (Pubitemid 43155682)
33. Feng Y, Hong X, Wilker E, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008;196:590-7